Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Immunoglobulin G × Genitourinary × Clear all

Phase

Status

Completed 8 Active not recruiting 8 Terminated 6 Recruiting 5 Withdrawn 3 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Genitourinary 1 Gastrointestinal 1 Breast 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Androgen Antagonists 14 Gemcitabine 11 pembrolizumab 10 Radiotherapy 10 Docetaxel 10 darolutamide 9 Specimen Handling 9 Radiosurgery 9 apalutamide 7 Drug Therapy 7 Abiraterone Acetate 6 abiraterone 5 Nivolumab 5 Magnetic Resonance Spectroscopy 5 Cystectomy 5 Brachytherapy 5 Biopsy 5 enzalutamide 4 enfortumab vedotin 4 disitamab vedotin 4 Pluvicto 4 Mitomycin 4 toripalimab 3 lenvatinib 3 cabozantinib 3 Sunitinib 3 Saline Solution 3 Prednisone 3 Leuprolide 3 Ipilimumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07332351 2026-03-13

TRIFECTA

University of Washington

Phase 2 Not yet recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡